Physician profile
Brandon Brownell
NPI 1861837361
$559.63
in general payments reported to CMS, 2019-2025
14 companies · $15.89 in 2025
The $15.89 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $403 · 2020: $78.68 · 2021: $28.57 · 2022: $15.96 · 2023: $17.64 · 2025: $15.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $33.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $33.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $197.77 | 2019-2021 | |
| Pacira Therapeutics, INC. | $106.97 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $52.51 | 2019 | |
| Bioventus LLC | $33.53 | 2023-2025 | Durolane, Durolane |
| Genentech USA, INC. | $28.60 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $25.07 | 2019 | |
| Abbott Laboratories | $16.81 | 2019 | |
| Allergan, INC. | $16.06 | 2020 | |
| Ferring Pharmaceuticals INC. | $15.96 | 2022 | |
| Gilead Sciences, INC. | $15.78 | 2019 | |
| Lilly USA, LLC | $15.10 | 2020 | |
| Sanofi Pasteur INC. | $13.64 | 2019 | |
| Seqirus USA INC | $10.97 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $10.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Brownell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.